Archive for the ‘china retractions’ Category
The Journal of Clinical Nursing is retracting a paper “due to major overlap with a previously published article” from the same journal, following an investigation by the National University of Singapore.
By our count, this is the third retraction for first author, Moon-fai Chan, all for “overlap” with other papers.
As we reported in May, the Journal of Advanced Nursing retracted a paper co-authored by Chan for “major overlap” with a paper in JCN, that too the result of the investigation. We’ve also learned that the journal Nursing & Health Sciences issued a similar notice last year for another pair of overlapped papers.
Chan said in a statement to Retraction Watch Read the rest of this entry »
A 2012 paper that analyzed injuries to aquatic mammals in China has been retracted “due to the usage of restricted data from the Ministry of Agriculture of China.”
The authors — from Shandong University in China, The University of Hong Kong and the Peruvian Centre for Cetacean Research — “organized the collection of official documents related to strandings, bycatches and injuries of aquatic mammals in the waters of mainland China from provincial fishery administrations for the years 2000 to 2006,” according to the abstract. However, they may not have been supposed to do that.
A 2015 paper on how proteins work to reduce inflammation in cow cells has been retracted by the authors “because of inappropriate statistical analysis and inability to reproduce some of the results.”
The journal Inflammation posted the retraction in August, just six months after it was published in February. It has only been cited once, according to Thomson Scientific’s Web of Knowledge.
Here’s the full retraction notice:
The Journal of Biological Chemistry has posted withdrawal notices for six papers that had already been withdrawn, some more than a decade ago, in an effort to resolve “PubMed indexing problems.”
Each paper had been pulled by the author before it appeared in print, but still appeared online on the the journal’s website and in PubMed.
By our count, the journal has posted six notices so far, and said we should expect to see more in the future.
Kaoru Sakabe the Manager of Publication Issues at the American Society for Biochemistry and Molecular Biology, which publishes JBC, provided a statement on the new withdrawal notices: Read the rest of this entry »
Researchers have pulled a paper about a drug used to treat pancreatic tumors due to “statistical errors.”
The 2014 paper suggested a drug that appears to treat pancreatic tumors also works in Chinese patients. We’re not exactly sure what went wrong with “A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients,” however, because the retraction note is not particularly helpful. Here’s the whole thing, published in Medical Oncology: Read the rest of this entry »
A pair of papers about the risks of titanium dioxide nanoparticles that share many of the same authors has been retracted from a toxicology journal following an investigation at Soochow University in China.
Particle and Fibre Toxicology is retracting the papers for problems with the statistical methods and missing data, as well as for sharing figures.
The retraction note for “Preparation and dielectric properties of BaTiO3:epoxy nanocomposites for embedded capacitor application” is short and sweet. Here it is, in full:
Editors at BioMed Central have taken the unusual step of updating a retraction notice after an investigation found the authors were not responsible for a peer review process gone awry. The paper is one of dozens of other papers retracted in March for fake peer reviews.
That month, the paper “Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia” in Diagnostic Pathology was among the 43 papers retracted due to fake peer reviews. (Retractions for the phenomenon — more about it in our Nature feature here — are up to about 170.)
According to the update posted in July, an investigation into the paper by the Jiading Central Hospital in Shanghai, where the authors work, found that they “did not participate in influencing the peer review process.”
Here’s more from the update to the notice:
Researchers have withdrawn a 2010 article in the Journal of Biological Chemistry about an immune regulator.
This article has been withdrawn by the authors.
The study’s authors were based out of Shandong University Medical School, Jinan General Hospital of Jinan Command and Duke University Medical Center.
Two of the authors have had previous papers retracted.
Expert Opinion on Therapeutic Patents has retracted a 2015 review article about natural fighters of cancer stem cells for reproducing “content to a high degree of similarity without appropriate attribution or acknowledgement” from a handful of papers.
Although the editor and publisher pulled the paper, they did so with the cooperation of the authors, according to the retraction note: Read the rest of this entry »